We are live on ! Find out more
CTNM

Contineum Therapeutics
CTNM

49 hedge funds and large institutions have $229M invested in Contineum Therapeutics in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.54% more ownership

Funds ownership: 0% → 68.54% (+69%)

Holders
49
Holders Change
+49
Holders Change %
–
% of All Funds
0.71%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.04%
New
49
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Suvretta Capital Management
New York
+$33.1M
2
JJ
Johnson & Johnson
New Jersey
+$31.9M
3
PA
Perceptive Advisors
New York
+$25.2M
4
VVM
Versant Venture Management
California
+$14.8M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$12.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Suvretta Capital Management
New York
$36.2M +$33.1M +2,053,334 New
JJ
2
Johnson & Johnson
New Jersey
$34.9M +$31.9M +1,979,173 New
PA
3
Perceptive Advisors
New York
$27.6M +$25.2M +1,566,668 New
VVM
4
Versant Venture Management
California
$16.2M +$14.8M +918,163 New
SAM
5
Sectoral Asset Management
Quebec, Canada
$14.1M +$12.9M +800,887 New
HA
6
HHLR Advisors
Cayman Islands
$11.8M +$10.8M +669,337 New
Franklin Resources
7
Franklin Resources
California
$11M +$10.1M +627,008 New
SB
8
Samsara BioCapital
California
$10.4M +$9.48M +588,817 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$8.31M +$7.6M +471,617 New
ACM
10
Altium Capital Management
New York
$7.56M +$6.91M +429,340 New
BlackRock
11
BlackRock
New York
$6.98M +$6.38M +396,273 New
Fidelity Investments
12
Fidelity Investments
Massachusetts
$5.7M +$5.21M +323,600 New
BBA
13
Baker Bros. Advisors
New York
$5.5M +$5.03M +312,500 New
CC
14
Casdin Capital
New York
$5.22M +$4.78M +296,666 New
Adage Capital Partners
15
Adage Capital Partners
Massachusetts
$5.19M +$4.75M +295,000 New
PCH
16
Polar Capital Holdings
United Kingdom
$3.78M +$3.45M +214,442 New
Norges Bank
17
Norges Bank
Norway
$2.93M +$2.68M +166,178 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$2.75M +$2.52M +156,421 New
Squarepoint
19
Squarepoint
New York
$2.64M +$2.42M +150,000 New
Citadel Advisors
20
Citadel Advisors
Florida
$2.25M +$2.06M +127,785 New
State Street
21
State Street
Massachusetts
$1.62M +$1.48M +91,806 New
SVCM
22
Saturn V Capital Management
Texas
$1.28M +$1.17M +72,831 New
DCM
23
Driehaus Capital Management
Illinois
$1.17M +$1.07M +66,667 New
Charles Schwab
24
Charles Schwab
California
$912K +$834K +51,772 New
Walleye Capital
25
Walleye Capital
New York
$778K +$712K +44,185 New
1
2

CTNM Hedge Fund Activity: Q2 2024 in Review

49 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Contineum Therapeutics (CTNM) for Q2 2024, worth a combined $229M.

Buyers outnumbered sellers: 49 funds opened new CTNM positions and 0 closed out — a net gain of 49 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Suvretta Capital Management, opening a new position worth an estimated $33.1M.

  • 49 institutional investors held Contineum Therapeutics (CTNM) as of Q2 2024, up from 0 in Q1 2024.
  • Funds reported $229M of Contineum Therapeutics stock for Q2 2024.
  • 49 funds opened new Contineum Therapeutics positions in Q2 2024 and 0 closed out, a net change of +49 holders.
  • The largest Contineum Therapeutics buyer in Q2 2024 was Suvretta Capital Management, an estimated $33.1M added.

Based on aggregated 13F filings for Q2 2024.